Free cashflow at end of dec is a little lower than expected given Curragh changed hands end of march 18 and average sale price around the US$150 mark. Absence of cost discussion suggests higher cost could be the problem - Curragh production decline is a concerning trend.
Solid pricing over FY19 should be in CRNs favour.
Looks like the business can generate around A$50M free cash per quarter so potential is A$150 for the total dividend in FY19 based on Oct 18 - June 19. 15 ish cents?
That is my guess.
Free cashflow at end of dec is a little lower than expected...
Add CRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
-0.020(2.13%) |
Mkt cap ! $1.567B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 95.5¢ | 92.0¢ | $791.5K | 846.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 38306 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.5¢ | 6553 | 3 |
View Market Depth
| Last trade - 16.10pm 21/11/2024 (20 minute delay) ? |
| CRN (ASX) Chart |
